Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shelley Allen

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Disability and Rehabilitation|June 16, 2011
Driving and driving cessation after traumatic brain injury: processes and key times of needJacki Liddle, Jennifer Fleming, Kryss McKenna, et al.
Australian Occupational Therapy Journal|January 26, 2012
Adjustment to loss of the driving role following traumatic brain injury: a qualitative exploration with key stakeholdersJacki Liddle, Jennifer Fleming, Kryss McKenna, et al.
International Psychogeriatrics|September 3, 2013
The stages of driving cessation for people with dementia: needs and challengesJacki Liddle, Sally Bennett, Shelley Allen, et al.
Australian Occupational Therapy Journal|February 10, 2016
Organisational support for evidence-based practice: occupational therapists perceptionsSally Bennett, Shelley Allen, Elizabeth Caldwell, et al.
International Psychogeriatrics|September 15, 2015
"The biggest problem we've ever had to face": how families manage driving cessation with people with dementiaJacki Liddle, Amelia Tan, Phyllis Liang, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2004
Discovery and SAR of trisubstituted thiazolidinones as CCR4 antagonistsShelley Allen, Bradley Newhouse, Aaron S Anderson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 6, 2015
The role of brain-derived neurotrophic factor (BDNF) in the development of neurogenic detrusor overactivity (NDO)Bárbara Frias, João Santos, Marlene Morgado, et al.
Cellular Immunology|November 15, 2011
The role of PIM kinases in human and mouse CD4+ T cell activation and inflammatory bowel diseaseLeila J Jackson, Jed A Pheneger, Tracy J Pheneger, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Racemic and chiral lactams as potent, selective and functionally active CCR4 antagonistsBradley Newhouse, Shelley Allen, Benjamin Fauber, et al.
Leukemia Research|August 2, 2011
A potential therapeutic target for FLT3-ITD AML: PIM1 kinaseAmir T Fathi, Omotayo Arowojolu, Ian Swinnen, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Disability and Rehabilitation|June 16, 2011
Driving and driving cessation after traumatic brain injury: processes and key times of needJacki Liddle, Jennifer Fleming, Kryss McKenna, et al.
Australian Occupational Therapy Journal|January 26, 2012
Adjustment to loss of the driving role following traumatic brain injury: a qualitative exploration with key stakeholdersJacki Liddle, Jennifer Fleming, Kryss McKenna, et al.
International Psychogeriatrics|September 3, 2013
The stages of driving cessation for people with dementia: needs and challengesJacki Liddle, Sally Bennett, Shelley Allen, et al.
Australian Occupational Therapy Journal|February 10, 2016
Organisational support for evidence-based practice: occupational therapists perceptionsSally Bennett, Shelley Allen, Elizabeth Caldwell, et al.
International Psychogeriatrics|September 15, 2015
"The biggest problem we've ever had to face": how families manage driving cessation with people with dementiaJacki Liddle, Amelia Tan, Phyllis Liang, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2004
Discovery and SAR of trisubstituted thiazolidinones as CCR4 antagonistsShelley Allen, Bradley Newhouse, Aaron S Anderson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 6, 2015
The role of brain-derived neurotrophic factor (BDNF) in the development of neurogenic detrusor overactivity (NDO)Bárbara Frias, João Santos, Marlene Morgado, et al.
Cellular Immunology|November 15, 2011
The role of PIM kinases in human and mouse CD4+ T cell activation and inflammatory bowel diseaseLeila J Jackson, Jed A Pheneger, Tracy J Pheneger, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Racemic and chiral lactams as potent, selective and functionally active CCR4 antagonistsBradley Newhouse, Shelley Allen, Benjamin Fauber, et al.
Leukemia Research|August 2, 2011
A potential therapeutic target for FLT3-ITD AML: PIM1 kinaseAmir T Fathi, Omotayo Arowojolu, Ian Swinnen, et al.
Pageof 3